Motilal Oswal BSE Healthcare ETF

A Other ETF scheme from Motilal Oswal Mutual Fund. Figures below are for the Regular · option not stated plan (ISIN INF247L01BB1).

NAV ₹53.3593 on 16 November 2026.

Expense ratio

Total expense ratio 0.36% a year for the Regular · option not stated plan, as AMFI published it on 29 October 2026: base expense ratio 0.21%, brokerage 0.02%, transaction costs 0.00%, statutory levies including GST 0.13%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino
1 year18.4%14.1%-10.0%0.810.86
3 years22.6%14.3%-16.1%1.091.05

Too little NAV history for the 5, 10-year figures.

Not ranked in its category: its category mixes funds too different to rank against one another.

Largest holdings

Top 10 (October 2026 disclosure). Company shares make up 99.9% of the portfolio.

  1. Sun Pharmaceutical Industries Limited — 11.97%
  2. Divi's Laboratories Limited — 7.72%
  3. Laurus Labs Limited — 5.80%
  4. Apollo Hospitals Enterprise Limited — 5.35%
  5. Dr. Reddy's Laboratories Limited — 5.13%
  6. Cipla Limited — 4.87%
  7. Max Healthcare Institute Limited — 3.97%
  8. Torrent Pharmaceuticals Limited — 3.41%
  9. Lupin Limited — 3.04%
  10. Aurobindo Pharma Limited — 2.89%

Plans

Other funds in Other ETF

All 232 funds in Other ETF · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.